NCT03678883 2024-11-079-ING-41 in Patients with Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT00004095 2017-04-18Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsNorthwestern UniversityPhase 1 Completed38 enrolled